Business Desk :
Beximco Pharma has won the prestigious Scrip Award in the category of ‘Best Company in an Emerging Market’ at the 13th Annual Scrip Awards ceremony held in London recently. Rabbur Reza, Chief Operating Officer of Beximco Pharma, accepted the award on behalf of the company, according to a press release issued yesterday. This is the first time a Bangladeshi company has won this global award which recognises company’s operational excellence and continued growth in global market, it said. The Scrip Awards honor the highest achieving companies and individuals in global pharma and biotech industry, recognising their important roles in improving healthcare around the world. A panel of 16 highly respected and independent judges from across diverse sectors evaluated the award entries to select the finalists.
Scrip’s Best Company in an Emerging Market Award seeks to reward the growing R&D-based pharmaceutical company founded in areas beyond its traditional geographic borders of North America, Western Europe and Japan. Previous winners in this category include globally reputed pharma companies like Dr Reddy’s, Hikma, Glenmark and Mundipharma.
On this occasion, Beximco Pharma Managing Director Nazmul Hassan MP said, “We are proud to be recognised as the ‘Best Company in an Emerging Market’ at the prestigious Scrip Awards. With its broad portfolio of generics and global footprint in more than 50 countries including US, EU and Australia, Beximco Pharma is continuing to expand its reach and impact around the world. We are setting a high standard for the country’s pharmaceutical industry through our research and development initiatives, strategic partnerships, and expansion programs.”
